In a heterogeneous cohort with aggressive manifestations of a rare disease such as acromegaly, any significant (or near-significant) difference observed may hold greater value than would be the case in a prospective study.
← all excerpts
The paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism.
1
—
—